X

NEW TONIN TROCHE L

Product Information

Registration Status: Active

SIN04537P

NEW TONIN TROCHE L is approved to be sold in Singapore with effective from 1990-05-21. It is marketed by SATO PHARMACEUTICAL (SINGAPORE) PTE LTD, with the registration number of SIN04537P.

This product contains Noscapine 60mg,Apricot Kernel Extract 125mg, and Glycyrrhiza Extract 60mg in the form of LOZENGE. It is approved for ORAL use.

This product is manufactured by SATO PHARMACEUTICAL CO LTD in JAPAN.

It is an Over-the-counter Medicine that can be freely obtained from any retailer

Product Reference
Loading...


Indication

Investigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), cancer/tumors (unspecified), and multiple myeloma.

Mechanism of Action

Noscapine's antitussive effects appear to be primarily mediated by its sigma receptor agonist activity. Evidence for this mechanism is suggested by experimental evidence in rats. Pretreatment with rimcazole, a sigma specific antagonist, causes a dose-dependent reduction in antitussive activity of noscapine.

Active Ingredient/Synonyms

CB3304 | Noscapine |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.



Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.



Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!